Stay updated on Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:07:40.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T23:48:41.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Page revision tag updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:01:53.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the previous Revision: v3.4.1. This is a minor site version update that does not change study details.
    Difference
    0.1%
    Check dated 2026-02-12T02:25:02.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page now displays 'Revision: v3.4.1', replacing the previous 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:06:45.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Adds a glossary toggle and updates footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0,' while removing older capitalization and wording.
    Difference
    0.2%
    Check dated 2026-01-28T19:03:35.000Z thumbnail image

Stay in the know with updates to Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.